AURA compared with ABVX: revenue, margins and what each company keeps, and the suppliers and customers both name

AURAAura Biosciences, Inc.

Mkt capRevenueRevenue

ABVXAbivax S.A.

Mkt capRevenueRevenue

Compare

AURAAura Biosciences, Inc.

ABVXAbivax S.A.

Price

Mkt cap

Revenue

Revenue flow

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

AURAAura Biosciences, Inc.

6.25▲+3.59%· post 6.25· delayed

Mkt cap$625.3M

ABVXAbivax S.A.

88.36▲+4.07%· post 88.36· delayed

After hoursNov 3 '26delayed

Mkt cap$5.9B

Compare

After hoursNov 3 '26delayed

AURAAura Biosciences, Inc.

ABVXAbivax S.A.

6.25▲+3.59%post 6.25delayed

Price

88.36▲+4.07%post 88.36delayed

$625.3M

Mkt cap

$5.9B

AURA6.25▲+3.59%vsABVX88.36▲+4.07%After hoursNov 3 '26delayed

AURA: latest quarter not drawable. ABVX: latest quarter not drawable.Method ›

direct ties · both sidesSources ›

direct ties · both sides

No disclosed counterparties: AURA, ABVX.

Role chip = supplier or customerSource: SEC EDGAR

rebased to 0%

AURA, solidABVX, dashed